FRRS1L Antibodies

Santa Cruz Biotechnology features a diverse variety of FRRS1L monoclonal antibodies for investigating FRRS1L protein function. FRRS1L monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FRRS1L, or Ferric Reductase Domain Containing 1-Like, plays a vital role in iron metabolism and cellular iron homeostasis. FRRS1L functions are essential for regulating iron levels within cells, which directly impacts oxygen transport and DNA synthesis. Research has shown that FRRS1L abnormalities contribute to several pathological conditions. Understanding FRRS1L activity provides valuable insights into cellular iron regulation mechanisms. FRRS1L research continues to reveal new aspects of iron metabolism and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FRRS1L and its role in human health and disease.